Vertex Pharmaceuticals, Inc.
XNAS: VRTX
Vertex Pharmaceuticals, Inc. Live Stock Price Today, Share Analysis and Chart
about
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...
Read More
392.05
2.97
(0.76%)
1.5M
XNAS Volume
XNAS 28 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Vertex Pharmaceuticals, Inc. is on 03 Sep 2025 for the purpose of 2025 Wells Fargo Healthcare Conference
See details
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks.
View Similar
Embed DVM
Vertex Pharma Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..